Soligenix SNGX
NASDAQ SNGX
$0.40 +0.02 (+5.50%)
At close: Aug 21, 2026 · 4:00 PM EDT

Soligenix (SNGX) Cost of Revenue (2010 - 2024)

Soligenix's (SNGX) quarterly Cost of Revenue came in at $2342.0 in Q2 2024, down 98.73% YoY from $184021.0 in Q3 2023, and down 98.0% on a QoQ basis from $117029.0 in Q1 2024.

Soligenix (SNGX) Cost of Revenue (2010 - 2024) Analysis & Trends

Soligenix (SNGX) has 15 years of Cost of Revenue data on file, last reported at $2342.0 in Q2 2024.

  • Quarterly Cost of Revenue fell 98.73% year-over-year to $2342.0 in Q2 2024, while the trailing twelve-month figure through Dec 2024 was $119371.0 (down 83.91% YoY) and the FY2024 annual result came in at $119371.0, down 83.91% from the prior year.
  • Cost of Revenue retreated to $2342.0 in Q2 2024, from $117029.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $829506.0 in Q1 2020 to a low of $2342.0 in Q2 2024.
  • A 5-year average of $220101.7 and a median of $188662.5 in 2022 frame the typical range for Cost of Revenue.
  • Annual changes were most pronounced in 2023 — Cost of Revenue surged 145.13% — and 2024, when it slumped 98.73%.
  • Tracing SNGX's Cost of Revenue over 5 years: stood at $241464.0 in 2020, then declined by 2.39% to $235698.0 in 2021, then slumped by 42.36% to $135865.0 in 2022, then surged by 63.06% to $221546.0 in 2023, then tumbled by 98.94% to $2342.0 in 2024.
  • The last three Cost of Revenue figures came in at $2342.0 (Q2 2024), $117029.0 (Q1 2024), and $221546.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 489.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 360.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 145.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 93.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 174.53 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 298.26 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 387.98 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 67.21 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Soligenix 6.45 Mn 6.45 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 2,342.00
Jun 30, 2024 2,342.00
Mar 31, 2024 117,029.00
Mar 31, 2024 117,029.00
Dec 31, 2023 221,546.00
Dec 31, 2023 221,546.00
Sep 30, 2023 110,441.00
Sep 30, 2023 110,441.00
Jun 30, 2023 184,021.00
Jun 30, 2023 184,021.00
Mar 31, 2023 226,040.00
Mar 31, 2023 226,040.00
Dec 31, 2022 135,865.00
Dec 31, 2022 135,865.00
Sep 30, 2022 129,440.00
Sep 30, 2022 129,440.00
Jun 30, 2022 193,304.00
Jun 30, 2022 193,304.00
Mar 31, 2022 92,213.00
Mar 31, 2022 92,213.00